EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections

Christian Münz iD

Cancers · 07.12.2023 · 15 (24) · 5739

DOI: 10.3390/cancers15245739 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.12.2023. Verfasst von Christian Münz. Beteiligte Einrichtung: Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Swiss MS Society, EU Horizon BEHIND-MS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oncogenic and persistent Epstein Barr virus (EBV) is carried by more than 95% of the human adult population. While asymptomatic in most of these, EBV can cause a wide variety of malignancies of lymphoid or epithelial cell origin. Some of these are also associated with co-infections that either increase EBV-induced tumorigenesis or weaken its immune control. The respective pathogens include Kaposi-sarcoma-associated herpesvirus (KSHV), Plasmodium falciparum and human immunodeficiency virus (HIV). In this review, I will discuss the respective tumor entities and possible mechanisms by which co-infections increase the EBV-associated cancer burden. A better understanding of the underlying mechanisms could allow us to identify crucial features of EBV-associated malignancies and defects in their immune control. These could then be explored to develop therapies against the respective cancers by targeting EBV and/or the respective co-infections with pathogen-specific therapies or vaccinations.

Schlagwörter

Stichwörter der Autor:innen

Burkitt’s lymphomaEpstein Barr virus (EBV)Helicobacter pyloriKaposi-sarcoma-associated herpesvirus (KSHV)Plasmodium falciparumhuman cytomegalovirus (HCMV)human immunodeficiency virus (HIV)human papilloma virus (HPV)malariaprimary effusion lymphoma (PEL)

Autor:innen und Institutionen

  • Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland.

ORCID-Profile: Christian Münz

Förderung

  • Swiss National Science Foundation
  • Swiss MS Society
  • EU Horizon BEHIND-MS
  • CRPP-ImmunoCure of the University of Zürich
  • Sobek Foundation
  • Swiss Vaccine Research Institute
  • Vontobel Foundation, Roche, Novartis and Viracta

Zitieren

APA

Münz, C. (2023). Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections. Cancers, 15(24), 5739. https://doi.org/10.3390/cancers15245739

Vancouver

Münz C. Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections. Cancers. 2023;15(24):5739. doi:10.3390/cancers15245739

BibTeX
@article{Mnz2023,
  author = {Münz, Christian},
  title = {Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {24},
  pages = {5739},
  doi = {10.3390/cancers15245739}
}
Kostenlos starten →